Upon completion of this program, the learner will be able to:

1. identify psychotropic medications that, when used concomitantly with opioids, increase risk for opioid related harm
2. describe the potential harms that may occur
3. Discuss risk management approached and therapeutic alternatives with lower risks of harm

Who should attend?

All members of a healthcare team to include, and not limited to: physicians, nurse practitioners, physician assistants, nurses, rehabilitation therapists, behavioral health providers, social workers, pharmacists, medication assisted treatment (MAT) prescribing providers, and prescribing providers interested in becoming MAT providers.

Why attend?

Because you will... 

• participate in case-based clinical discussions focused on the treatment of opioid use disorder (OUD)
• gain up-to-date knowledge of OUD treatment through brief didactic presentations on topics on interest to learners
• improve your confidence in managing patients with OUD

Presenter: Amy Werremeyer, PharmD, BCPP

For additional content information contact: Julie Reiten, julie.a.reiten or call 701.777.4173
 

Continuing Education:

The University of North Dakota School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of North Dakota School of Medicine and Health Sciences designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim credit commensurate with the extent of their participation in the activity.

This project is provided by UND's School of Medicine and Health Sciences ProjectECHO supported by HRSA contract number HHSH250201600015C and in collaboration with the MPATTC.